Symbol="TARA"
AssetType="Common Stock"
Name="Protara Therapeutics Inc"
Description="Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to identifying and promoting transformative therapies for the treatment of cancer and rare diseases. The company is headquartered in New York, New York."
CIK="1359931"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="200 WEST STREET, WALTHAM, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="26234600"
EBITDA="-36134000"
PERatio="None"
PEGRatio="None"
BookValue="8.38"
DividendPerShare="0"
DividendYield="0"
EPS="-5.75"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.17"
ReturnOnEquityTTM="-0.52"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-5.75"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="33.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.241"
EVToRevenue="-"
EVToEBITDA="1.595"
Beta="1.47"
num_52WeekHigh="4.6"
num_52WeekLow="2.2"
num_50DayMovingAverage="2.882"
num_200DayMovingAverage="3.141"
SharesOutstanding="11308000"
DividendDate="2020-01-10"
ExDividendDate="None"
symbol="TARA"
open="2.32"
high="2.37"
low="2.27"
price="2.32"
volume="20345.00"
latest_trading_day="2023-07-07"
previous_close="2.31"
change="0.01"
change_percent="0.4329%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="78"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="22"
Volume_recent_avg="33582"
Change_recent_avg="-0.03"
Delta_recent_avg="0.25"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="-1.04"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="22"
Aroon_momentum_negative="78"
image_negative_thumbnail_id_1="123"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0053.jpeg"
image_negative_thumbnail_id_2="157"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0019.jpeg"
image_neutral_thumbnail_id_1="564"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0035.jpeg"
image_neutral_thumbnail_id_2="544"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_positive_thumbnail_id_1="975"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0137.jpeg"
image_positive_thumbnail_id_2="644"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0064.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1195"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
